Über uns


1. Thöne P, Egger M, Geroldinger-Simic M, Kindermann H, Kocik L, Karasek N, Fischerlehner B, Spiegl K, Gruber G, Aschacher B, Dieplinger B, Clodi M, Geinitz H. Immunogenicity parameters of cancer patients receiving the mRNA vaccine BNT162b2 while obtaining radiotherapy: a longitudinal cohort evaluation. Vaccines 2024;12:275. [PubMed]

2. Geinitz H, Silberberger E, Spiegl K, Feichtinger J, Wagner H, Hermann P, Bräutigam E, Track C, Weis EM, Venhoda C, Hupperl R, Spindelbalker-Renner B, Zauner-Babor G, Nyri DV, Karasek N, Erdei M, Gheju R, Gruber G, Egger M, Dieplinger B. SARS-CoV-2 vaccination willingness and humoral vaccination response in radiation oncology patients. Vaccine 2024;42:945-59. [PubMed]

1. Egger M, Black A, Robier C. Coincidence of plasma cell leukemia and COVID-19: a diagnostic pitfall. J Hematop 2023;16:127-8. [PubMed]  

2. Heimerl S, Höring M, Kopczynski D, Sigruener A, Hart C, Burkhardt R, Black A, Ahrends R, Liebisch G. Quantification of bulk lipid species in human platelets and their thrombin-induced release. Sci Rep 2023;13:6154. [PubMed]

3. Dikaios I, Althaus H, Angles-Cano E, Ceglarek U, Coassin S, Cobbaert CM, Delatour V, Dieplinger B, Grimmler M, Hoofnagle AN, Kostner GM, Kronenberg F, Kuklenyik Z, Lyle AN, Prinzing U, Ruhaak LR, Scharnagl H, Vesper HW, Deprez L. Commutability Assessment of Candidate Reference Materials for Lipoprotein(a) by Comparison of a MS-based Candidate Reference Measurement Procedure with Immunoassays. Clin Chem 2023;69:262-272. [PubMed]

1. Feldbauer R, Heinzl MW, Klammer C, Resl M, Pohlhammer J, Rosenberger K, Almesberger V, Obendorf F, Schinagl L, Wagner T, Egger M, Dieplinger B, Clodi M. Effect of Repeated Bolus and Continuous Glucose Infusion on a Panel of Circulating Biomarkers in Healthy Volunteers. PLoS One 2022;17:e0279308. [PubMed]

2. Heinzl MW, Kolenchery L, Resl M, Klammer C, Black A, Obendorf F, Schinagl L, Feldbauer R, Pohlhammer J, Wagner T, Berger T, Dieplinger B, Clodi M. High anti-CoV2S antibody levels at hospitalization are associated with improved survival in patients with Covid-19 vaccine breakthrough infection. Int J Environ Res Public Health 2022;19:15581. [PubMed]

3. Pohlhammer J, Heinzl MW, Klammer C, Feldbauer R, Rosenbergerd K, Resl M, Wagner T, Obendorf F, Egger M, Dieplinger B, Clodi M. Glucose and lipopolysaccharide differentially regulate Fibroblast Growth Factor 21 in healthy male human volunteers – a prospective cross-over trial. J Cell Mol Med 2022;26:5998-6005. [PubMed]

4. Hammer F, Genser B, Dieplinger B, Egger M, Müller T, Drechsler C, März W, Störk S, Wanner C, Krane V. Soluble suppression of tumorigenesis-2 is a strong predictor of all-cause, cardiovascular and infection-related mortality risk in haemodialysis patients with diabetes mellitus. Clin Kidney J 2022;15:1915-23. [PubMed]

5. Heinzl MW, Resl M, Klammer C, Fellinger P, Schinagl L, Obendorf F, Feldbauer R, Pohlhammer J, Wagner T, Egger M, Dieplinger B, Clodi M. Subclinical kidney injury is caused by a moderate single inflamatory event. Shock 2022;58:14-9. [PubMed]

1. Pitkänen N, Finkenstedt A, Lamina C, Juonala M, Kähönen M, Mäkelä KM, Dieplinger B, Viveiros A, Melmer A, Leitner I, Kedenko L, Seppälä I, Viikari JSA, Mueller T, Kronenberg F, Paulweber B, Lehtimäki T, Zoller H, Raitakari OT, Dieplinger H. Afamin predicts the prevalence and incidence of nonalcoholic fatty liver disease. Clin Chem Lab Med 2021;60:243-51. [PubMed]

2. Millischer M, Heinzl M, Faka A, Resl M, Trepci A, Klammer C, Egger MDieplinger B, Clodi M, Schwieler L. Intravenous administration of LPS activates the kynurenine pathway in healthy male human subjects: a prospective placebo-controlled cross-over trial. J Neuroinflammation 2021;17;18(1):158. [PubMed]

3. Robier C, Hoefler G, Egger M. Simultaneous occurrence of EDTA-dependent lymphoagglutination and agglutination of myeloid cells in a patient with chronic myelomonocytic leukemia. Clin Chem Lab Med 2021;30;59(12):e458-e460. [PubMed]

4. Klausberger M, Duerkop M, Haslacher H, Wozniak-Knopp G, Cserjan-Puschmann M, Perkmann T, Lingg N, Aguilar PP, Laurent E, De Vos J, Hofner M, Holzer B, Stadler M, Manhart G, Vierlinger K, Egger M, Milchram L, Gludovacz E, Marx N, Köppl C, Tauer C, Beck J, Maresch D, Grünwald-Gruber C, Strobl F, Satzer P, Stadlmayr G, Vavra U, Huber J, Wahrmann M, Eskandary F, Breyer MK, Sieghart D, Quehenberger P, Leitner G, Strassl R, Egger AE, Irsara C, Griesmacher A, Hoermann G, Weiss G, Bellmann-Weiler R, Loeffler-Ragg J, Borth N, Strasser R, Jungbauer A, Hahn R, Mairhofer J, Hartmann B, Binder NB, Striedner G, Mach L, Weinhäusel A, Dieplinger B, Grebien F, Gerner W, Binder CJ, Grabherr R. A comprehensive antigen production and characterisation study for easy-to-implement, specific and quantitative SARS-CoV-2 serotests. EBioMedicine 2021 Apr 24;67:103348 [PubMed]

5. Robier C, Knaus G, Egger M. Acquired Pelger-Huet anomaly in two patients with chronic lymphocytic leukemia treated with venetoclax. Clin Chem Lab Med 2021;14;59(10):e395-e397. [PubMed]

6. Resl M, Heinzl MW, Klammer C, Egger M, Feldbauer R, Pohlhammer J, Dieplinger B, Clodi M. Storm of Cardiovascular Markers After LPS Administration in Human Volunteers. J Cardiovasc Transl Res 2021;14(5):941-947. [PubMed]

7. Egger MBundschuh CWiesinger K, Bräutigam E, Berger T, Clodi M, Dieplinger B. Prevalence of SARS-CoV-2 antibodies in health care personnel of two acute care hospitals in Linz, Austria. Clin Chem Lab Med 2021;59:e231-4. [PubMed]

1. Bundschuh CEgger MWiesinger K, Gabriel C, Clodi M, Mueller T, Dieplinger B. Evaluation of the EDI enzyme linked immunosorbent assays for the detection of SARS-CoV-2 IgM and IgG antibodies in human plasma. Clin Chim Acta 2020;509:79-82. [PubMed]

2. Egger MBundschuh CWiesinger K, Gabriel C, Clodi M, Mueller T, Dieplinger B. Comparison of the Elecsys Anti-SARS-CoV-2 immunoassay with the EDI enzyme linked immunosorbent assays for the detection of SARS-CoV-2 antibodies in human plasma. Clin Chim Acta 2020;509:18-24. [PubMed]

3. Schmid J, Beer M, Berghold A, Stojakovic T, Scharnagl H, Dieplinger B, Quasthoff S, Binder JS, Rainer PP. Cardiac involvement in a cross-sectional cohort of myotonic dystrophies and other skeletal myopathies. ESC Heart Fail 2020;7:1900-8. [PubMed]

4. Dieplinger BEgger M, Luft C, Hinterreiter F, Pernerstorfer T, Mueller T. Monitoring of unfractionated heparin therapy with anti-activated factor X activity in patients with aortic aneurysm undergoing an endovascular procedure. J Vasc Surg 2020;71:1454-5. [PubMed]

5. Dieplinger BEgger M, Jezek C, Heinisch-Finke C, Altendorfer C, Pernerstorfer T, Hefler L, Pateisky N, Mueller T. Implementation of a Comprehensive Unit-based Safety Program to reduce surgical site infections in cesarean delivery. Am J Infect Control 2020;4:386-90. [PubMed]

6. Heinzl M, Resl M, Klammer C, Egger MDieplinger B, Clodi M. Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) is not induced in artificial human inflammation and is not correlated with inflammatory response. Infect Immun 2020;88:e00842-19. [PubMed]

7. Obendorf F, Klammer C, Heinzl M, Egger-Salmhofer M, Resl M, Dieplinger B, Clodi M. Intra-hospital mortality of influenza patients during the 2017/2018 influenza season – report of a tertiary care hospital in Austria. Wien Med Wochenschr 2020;132:176-81. [PubMed]

1. Francic V, Keppel M, Schwetz V, Trummer C, Pandis M, Borzan V, Grübler MR, Verheyen ND, Kleber ME, Delgado G, Moissl AP, Dieplinger B, März W, Tomaschitz A, Pilz S, Obermayer-Pietsch B. Are soluble ST2 levels influenced by vitamin D and/or the seasons? Endocr Connect 2019;8:691–700. [PubMed]

2. Scharnagl H, Stojakovic T, Dieplinger B, Dieplinger H, Erhart G, Kostner GM, Hermann M, März W, Grammer TB. Comparison of lipoprotein (a) serum concentrations measured by six commercially available immunoassays. Atherosclerosis 2019;289:206-13. [PubMed

3. Pusceddul I, Dieplinger B, Mueller T. ST2 and the ST2/IL-33 signalling pathway-biochemistry and pathophysiology in animal models and humans. Clin Chim Acta 2019;495:493-500. [PubMed

4. Egger M, Maier E, Robier C. Light chain myeloma with bar-shaped intranuclear kappa light chain inclusions. Ann Hematol 2019;98:2237-8. [PubMed

5. Dieplinger BEgger MHaltmayer MMueller T, Luft C, Hinterreiter F, Pernerstorfer T. Reply: Activated clotting time monitoring in vascular surgery: so bad, no bad. J Vasc Surg 2019;69:1651-2. [PubMed

1. Mueller T, Egger M, Peer E, Jani E, Dieplinger B. Evaluation of sex-specific cut-off values of high-sensitivity cardiac troponin I and T assays in an emergency department setting - Results from the Linz Troponin (LITROP) study. Clin Chim Acta 2018;487:66-74. [PubMed]

2. Robier C, Hoefler G, Egger M, Hubmann E. Atypical „hairy cell-like“ presentation of leukemic mantle cell lymphoma. Clin Chem Lab Med 2018;485:195-204. [PubMed

3. Mueller TEgger M, Peer E, Dieplinger B. 5th generation cardiac troponin I and T assays in clinical routine - a head-to-head comparison with data from the Linz Troponin (LITROP) study. Clin Chim Acta 2018;485:195–204. [PubMed]

4. Hacker S, Dieplinger B, Werba G, Nickl S, Roth GA, Krenn CG, Mueller T, Ankersmit HJ, Haider T. Increased Serum Concentrations of Soluble ST2 Predict Mortality after Burn Injury. Clin Chem Lab Med 2018;56:2079-87. [PubMed]

5. Schmid J, Liesinger L, Birner-Gruenberger R, Stojakovic T, Scharnagl H, Dieplinger B, Asslaber M, Radl R, Beer M, Polacin M, Mair J, Szolar D, Berghold A, Quasthoff S, Binder JS, Rainer P. Elevated Measured Cardiac Troponin T in Skeletal Myopathies: New Evidence for a Skeletal Muscle Origin. J Am Coll Cardiol 2018;71:1540-9. [PubMed]

6. Dieplinger BEgger M, Luft C, Hinterreiter F, Pernerstorfer T, Haltmayer MMueller T. Comparison between activated clotting time and anti-activated factor X activity for the monitoring of unfractionated heparin therapy in patients with aortic aneurysm undergoing endovascular procedure. J Vasc Surg 2018;68:400-7. [PubMed]

7. Tramontana A, Dieplinger B, Stangl G, Hafner E, Dieplinger H. First trimester serum afamin concentrations are associated with the development of pre-eclampsia and gestational diabetes mellitus in pregnant women. Clin Chim Acta 2018;476:160-6. [PubMed]

8. Egger MDieplinger BMueller T. One-year in vitro stability of cardiac troponins and galectin-3 in different sample types. Clin Chim Acta 2018;476:117-22. [PubMed]

9. Weiss TW, Rohla M, Dieplinger B, Domanovits H, Fries D, Vosko MR, Gary T, Ay C. Edoxaban for stroke prevention in atrial fibrillation and treatment of venous thromboembolism: an expert position paper. Wien Med Wochenschr 2018;168:133–43. [PubMed

1. Mueller T, Hinterreiter F, Poelz W, Haltmayer MDieplinger B. The heart matters in diabetes: Ten-year outcomes of peripheral artery disease. SAGE Open Med 2017;5:1-12. [PubMed]

2. Iapichino GE, Ponschab M, Cadamuro J, Süssner S, Gabriel C, Dieplinger BEgger M, Schlimp CJ, Bahrami S, Schöchl H. Concentrated lyophilized plasma used for reconstitution of whole blood leads to higher coagulation factors activity but unchanged thrombin potential compared to fresh frozen plasma. Tranfusion 2017;57:1763-71. [PubMed

3. Dieplinger B, Bocksrucker C, Egger M, Eggers C, Haltmayer MMueller T. Prognostic value of inflammatory and cardiovascular biomarkers for prediction of 90-day all-cause mortality after acute Ischemic stroke – Results from the Linz Stroke Unit (LISU) study. Clin Chem 2017;63:1101-9. [PubMed

1. Mueller T, Gegenhuber A, Leitner I, Poelz W, Haltmayer MDieplinger B. Diagnostic and prognostic accuracy of galectin-3 and soluble ST2 for acute heart failure. Clin Chim Acta 2016;463:158-64. [PubMed]  

2. Mueller TDieplinger B. Soluble ST2 and Galectin-3: What we know and don't know analytically. EJIFCC 2016;27:224-37. [PubMed

3. Natriuretic Peptides Studies Collaboration. Natriuretic peptides and integrated risk assessment for cardiovascular disease: an individual-participant-data meta-analysis. Lancet Diabetes Endocrinol 2016;4:840-9. [PubMed]   

4. Dieplinger BEgger MLeitner I, Firlinger F, Poelz W, Lenz K, Haltmayer MMueller T. Interleukin-6, galectin-3, GDF-15, and soluble ST2 for mortality prediction in critically ill patients. J Crit Care 2016;34:38-45. [PubMed]  

5. Zimmermann M, Traxler D, Simader E, Bekos C, Dieplinger B, Lainscak M, Ankersmit HJ, Mueller T. In vitro stability of heat shock protein 27 in serum and plasma under different preanalytical conditions: implications for large-scale clinical studies. Ann Lab Med 2016;36:353-7. [PubMed]  

6. Mueller T, Hinterreiter F, Poelz W, Haltmayer MDieplinger B. Mortality rates at ten years are higher in diabetic than in non-diabetic patients with chronic lower extremity peripheral arterial disease. Vasc Med 2016;21:445-52.  [PubMed]

7. Mueller TEgger M, Leitner I, Gabriel C, Haltmayer M, Dieplinger B. Reference values of galectin-3 and cardiac troponins derived from a single cohort of healthy blood donors. Clin Chim Acta 2016;456:19–23. [PubMed]

1. Dieplinger BEgger M, Gegenhuber A, Haltmayer MMueller T. Analytical and clinical evaluation of a rapid quantitative lateral flow immunoassay for measurement of soluble ST2 in human plasma. Clin Chim Acta 2015;451:310-5. [PubMed]

2. Mueller T, Gegenhuber A, Kronabethleitner G, Leitner IHaltmayer MDieplinger B. Plasma concentrations of novel cardiac biomarkers before and after hemodialysis session. Clin Biochem 2015;48:1163-6. [PubMed]

3. Vazquez F, Rodger M, Carrier M, Le Gal G, Reny JL, Sofi F, Mueller T, Nagpal S, Jetty P, Gandara E. Prothrombin G20210A mutation and lower extremity peripheral arterial disease: a systematic review and meta-analysis. Eur J Vasc Endovasc Surg 2015;50:232-40. [PubMed]  

4. Robier C, Egger MWiesinger K, Aigner R, Neubauer M. Progression from light chain myeloma to secondary plasma cell leukemia accompanied by peripheral blood eosinophilia. Clin Chem Lab Med 2015;53:e305-7. [PubMed]  

5. Dieplinger H, Dieplinger B. Afamin – a pleiotropic glycoprotein involved in various disease states. Clin Chim Acta 2015;446:105-10. [PubMed

6. Steinbacher P, Feichtinger RG, Kedenko L, Kedenko I, Reinhardt S, Schönauer AL, Leitner I, Sänger AM, Stoiber W, Kofler B, Förster H, Paulweber B, Ring-Dimitriou S. The single nucleotide polymorphism Gly482Ser in the PGC-1 gene impairs exercise-induced slow-twitch muscle fibre transformation in humans. PLoS One 2015;10:e0123881. [PubMed

7. Mueller TLeitner IEgger MHaltmayer MDieplinger B. Association of the biomarkers soluble ST2, galectin-3 and growth-differentiation factor-15 with heart failure and other non-cardiac diseases. Clin Chim Acta 2015;445:155-60.  [PubMed]

8. Mueller T, Jaffe AS. Soluble ST2-analytical considerations. Am J Cardiol 2015;115(7 Suppl):8B-21B. [PubMed]

9. Richards AM, Di Somma S, Mueller T. ST2 in Stable and unstable ischemic heart diseases. Am J Cardiol 2015;115(7 Suppl):48B-58B. [PubMed]

10. Resl M, Vila G, Grimm G, Heinisch BB, Riedl M, Dieplinger BMueller T, Luger A, Clodi M. Effects of B-type natriuretic peptide on cardiovascular biomarkers in healthy volunteers. J Appl Physiol 2015;118:395-9. [PubMed]

11. Dieplinger BMueller T. Soluble ST2 in heart failure. Clin Chim Acta 2015;443:57-70. [PubMed]

1. Lenz K, Dieplinger B, Buder R, Piringer P, Rauch M, Voglmayr M. Successful treatment of partial portal vein thrombosis (PVT) with low dose rivaroxaban. Z Gastroenterol 2014;52:1175-7. [PubMed]

2. Zimmermann M, Mueller TDieplinger B, Bekos C, Beer L, Hofbauer H, Dome B, Ankersmit HJ. Circulating heat shock protein 27 as a biomarker for the differentiation of patients with lung cancer and healthy controls -- a clinical comparison of different enzyme linked immunosorbent assays. Clin Lab 2014;60:999-1006. [PubMed]  

3. Webersinke G, Kranewitter W, Deutschbauer S, Zach O, Hasenschwandtner S, Wiesinger K, Erdel M, Marschon R, Böhm A, Tschurtschenthaler G. Switch of the mutation type of the NPM1 gene in acute myeloid leukemia (AML): relapse or secondary AML? Blood Cancer J 2014;4:e221. [PubMed]

4. Luketina RR, Knauer M, Köhler G, Koch OO, Strasser K, Egger M, Emmanuel K. Comparison of a standard CO pressure pneumoperitoneum insufflator versus AirSeal: study protocol of a randomized controlled trial. Trials 2014;15:239. [PubMed]

5. Hubalek M, Buchner H, Mörtl MG, Schlembach D, Huppertz B, Firulovic B, Köhler W, Hafner E, Dieplinger B, Wildt L, Dieplinger H. The vitamin E-binding protein afamin increases in maternal serum during pregnancy. Clin Chim Acta 2014;434:41-7. [PubMed]

6. Dieplinger BEgger MHaltmayer M, Kleber ME, Scharnagl H, Silbernagel G, de Boer RA, Maerz M, Mueller T. Increased soluble ST2 predicts long-term mortality in patients with stable coronary artery disease - results from the Ludwigshafen Risk and Cardiovascular Health (LURIC) study. Clin Chem 2014;60:530-40. [PubMed]

7. Mueller T, Hinterreiter F, Luft C, Poelz W, Haltmayer MDieplinger B. Mortality rates and mortality predictors in patients with symptomatic peripheral artery disease stratified according to age and diabetes. J Vasc Surg 2014;59:1291-9. [PubMed]

8. Shah R, Gayat E, Januzzi JL, Sato N, Cohen-Solal A, Disomma S, Fairman E, Harjola VP, Ishihara S, Lassus J, Maggioni A, Metra M, Mueller C, Mueller T, Parenica J, Pascual-Figal D, Peacock F, Spinar J, van Kimmenade R, Mebazaa A; For the GREAT Network. Body mass index and mortality in acutely decompensated heart failure across the world: A global obesity paradox. J Am Coll Cardiol 2014;63:778-85. [PubMed]

1. Dieplinger BEgger M, Gabriel C, Poelz W, Morandell E, Seeber B, Kronenberg F, Haltmayer MMueller T, Dieplinger H. Analytical characterization and clinical evaluation of an enzyme-linked immunosorbent assay for measurement of afamin in human plasma. Clin Chim Acta 2013;425:236-41. [PubMed]  

2. Schwaiger JP, Nakada Y, Berberich R, Ikewaki K, Dieplinger B, Zitt E, Neyer U, Salmhofer H, Kronenberg F, Koenig P, Dieplinger H. Lipoprotein Kinetics in Male Hemodialysis Patients Treated with Atorvastatin. Clin J Am Soc Nephrol 2013;8:1319-26. [PubMed]

3. Lassus J, Gayat E, Mueller C, Peacock WF, Spinar J, Harjola VP, van Kimmenade R, Pathak A, Mueller T, Disomma S, Metra M, Pascual-Figal D, Laribi S, Logeart D, Nouira S, Sato N, Potocki M, Parenica J, Collet C, Cohen-Solal A, Januzzi JL Jr, Mebazaa A; for the GREAT-network. Incremental value of biomarkers to clinical variables for mortality prediction in acutely decompensated heart failure: The Multinational Observational Cohort on Acute Heart Failure (MOCA) study. Int J Cardiol 2013;168:2186-94. [PubMed]

4. Mebazaa A, Gayat E, Lassus J, Meas T, Mueller C, Maggioni A, Peacock F, Spinar J, Harjola VP, van Kimmenade R, Pathak A, Mueller T, Tavazzi L, Disomma S, Metra M, Pascual-Figal D, Laribi S, Logeart D, Nouira S, Sato N, Parenica J, Deye N, Boukef R, Collet C, Van den Berghe G, Cohen-Solal A, Januzzi JL Jr; GREAT Network. Association Between Elevated Blood Glucose and Outcome in Acute Heart Failure: Results From an International Observational Cohort. J Am Coll Cardiol 2013;61:820-9. [PubMed]

5. Mueller TDieplinger B. The Presage(®) ST2 Assay: analytical considerations and clinical applications for a high-sensitivity assay for measurement of soluble ST2. Expert Rev Mol Diagn 2013;13:13-30. [PubMed]

6. Melmer A, Fineder L, Lamina C, Kollerits B, Dieplinger B, Braicu I, Sehouli J, Cadron I, Vergote I, Mahner S, Zeimet AG, Castillo-Tong DC, Ebenbichler CF, Zeillinger R, Dieplinger H. Plasma concentrations of the vitamin E-binding protein afamin are associated with overall and progression-free survival and platinum sensitivity in serous ovarian cancer - a study by the OVCAD consortium. Gynecol Oncol 2013;128:38-43. [PubMed]

1. Mueller TDieplinger B. The guanylin peptide family and the proposed gastrointestinal-renal natriuretic signaling axis. Kidney Int 2012;82:1253-5. [PubMed]

2. Frischmann ME, Ikewaki K, Trenkwalder E, Lamina C, Dieplinger B, Soufi M, Schweer H, Schaefer JR, König P, Kronenberg F, Dieplinger H. In vivo stable-isotope kinetic study suggests intracellular assembly of lipoprotein(a). Atherosclerosis 2012;225:322-7. [PubMed]

3. Helgadottir A, Gretarsdottir S, Thorleifsson G, Holm H, Patel RS, Gudnason T, Jones GT, van Rij AM, Eapen DJ, Baas AF, Tregouet DA, Morange PE, Emmerich J, Lindblad B, Gottsäter A, Kiemeny LA, Lindholt JS, Sakalihasan N, Ferrell RE, Carey DJ, Elmore JR, Tsao PS, Grarup N, Jørgensen T, Witte DR, Hansen T, Pedersen O, Pola R, Gaetani E, Magnadottir HB, Wijmenga C, Tromp G, Ronkainen A, Ruigrok YM, Blankensteijn JD, Mueller T, Wells PS, Corral J, Soria JM, Souto JC, Peden JF, Jalilzadeh S, Mayosi BM, Keavney B, Strawbridge RJ, Sabater-Lleal M, Gertow K, Baldassarre D, Nyyssönen K, Rauramaa R, Smit AJ, Mannarino E, Giral P, Tremoli E, de Faire U, Humphries SE, Hamsten A, Haraldsdottir V, Olafsson I, Magnusson MK, Samani NJ, Levey AI, Markus HS, Kostulas K, Dichgans M, Berger K, Kuhlenbäumer G, Ringelstein EB, Stoll M, Seedorf U, Rothwell PM, Powell JT, Kuivaniemi H, Onundarson PT, Valdimarsson E, Matthiasson SE, Gudbjartsson DF, Thorgeirsson G, Quyyumi AA, Watkins H, Farrall M, Thorsteinsdottir U, Stefansson K. Apolipoprotein(a) genetic sequence variants associated with systemic atherosclerosis and coronary atherosclerotic burden but not with venous thromboembolism. J Am Coll Cardiol 2012;60:722-9. [PubMed]

4. Mueller T, Zimmermann M, Dieplinger B, Ankersmit HJ, Haltmayer M. Comparison of plasma concentrations of soluble ST2 measured by three different commercially available assays: the MBL ST2 assay, the Presage ST2 assay, and the R&D ST2 assay. Clinica Chimica Acta 2012;413:1493–94. [PubMed]

5. Vila G, Grimm G, Resl M, Heinisch B, Einwallner E, Esterbauer H, Dieplinger BMueller T, Luger A, Clodi M. B-Type natriuretic peptide modulates ghrelin, hunger, and satiety in healthy men. Diabetes 2012;61:2592-6. [PubMed]

6. Wassel CL, Lamina C, Nambi V, Coassin S, Mukamal KJ, Ganesh SK, Jacobs DR Jr, Franceschini N, Papanicolaou GJ, Gibson Q, Yanek LR, van der Harst P, Ferguson JF, Crawford DC, Waite LL, Allison MA, Criqui MH, McDermott MM, Mehra R, Cupples LA, Hwang SJ, Redline S, Kaplan RC, Heiss G, Rotter JI, Boerwinkle E, Taylor HA, Eraso LH, Haun M, Li M, Meisinger C, O'Connell JR, Shuldiner AR, Tybjærg-Hansen A, Frikke-Schmidt R, Kollerits B, Rantner B, Dieplinger B, Stadler M, Mueller THaltmayer M, Klein-Weigel P, Summerer M, Wichmann HE, Asselbergs FW, Navis G, Leach IM, Brown-Gentry K, Goodloe R, Assimes TL, Becker DM, Cooke JP, Absher DM, Olin JW, Mitchell BD, Reilly MP, Mohler ER 3rd, North KE, Reiner AP, Kronenberg F, Murabito JM. Genetic determinants of the ankle-brachial index: A meta-analysis of a cardiovascular candidate gene 50K SNP panel in the candidate gene association resource (CARe) consortium. Atherosclerosis 2012;222:138-47. [PubMed]

7. Murabito JM, White CC, Kavousi M, Sun YY, Feitosa MF, Nambi V, Lamina C, Schillert A, Coassin S, Bis JC, Broer L, Crawford DC, Franceschini N, Frikke-Schmidt R, Haun M, Holewijn S, Huffman JE, Hwang SJ, Kiechl S, Kollerits B, Montasser ME, Nolte IM, Rudock ME, Senft A, Teumer A, van der Harst P, Vitart V, Waite LL, Wood AR, Wassel CL, Absher DM, Allison MA, Amin N, Arnold A, Asselbergs FW, Aulchenko Y, Bandinelli S, Barbalic M, Boban M, Brown-Gentry K, Couper DJ, Criqui MH, Dehghan A, den Heijer M, Dieplinger B, Ding J, Dörr M, Espinola-Klein C, Felix SB, Ferrucci L, Folsom AR, Fraedrich G, Gibson Q, Goodloe R, Gunjaca G, Haltmayer M, Heiss G, Hofman A, Kieback A, Kiemeney LA, Kolcic I, Kullo IJ, Kritchevsky SB, Lackner KJ, Li X, Lieb W, Lohman K, Meisinger C, Melzer D, Mohler ER 3rd, Mudnic I, Mueller T, Navis G, Oberhollenzer F, Olin JW, O'Connell J, O'Donnell CJ, Palmas W, Penninx BW, Petersmann A, Polasek O, Psaty BM, Rantner B, Rice K, Rivadeneira F, Rotter JI, Seldenrijk A, Stadler M, Summerer M, Tanaka T, Tybjærg-Hansen A, Uitterlinden AG, van Gilst WH, Vermeulen SH, Wild SH, Wild PS, Willeit J, Zeller T, Zemunik T, Zgaga L, Assimes TL, Blankenberg S, Boerwinkle E, Campbell H, Cooke JP, de Graaf J, Herrington D, Kardia SL, Mitchell BD, Murray A, Münzel T, Newman A, Oostra BA, Rudan I, Shuldiner AR, Snieder H, van Duijn CM, Völker U, Wright AF, Wichmann HE, Wilson JF, Witteman JC, Liu Y, Hayward C, Borecki IB, Ziegler A, North KE, Cupples LA, Kronenberg F. Association between chromosome 9p21 variants and the ankle-brachial index identified by a meta-analysis of 21 genome-wide association studies. Circ Cardiovasc Genet 2012;5:100-12. [PubMed]

8. Heinisch BB, Vila G, Resl M, Riedl M, Dieplinger BMueller T, Luger A, Pacini G, Clodi M. B-type natriuretic peptide (BNP) affects the initial response to intravenous glucose: a randomised placebo-controlled cross-over study in healthy men. Diabetologia 2012;55:1400-5. [PubMed]

9. Dieplinger BEgger MKoehler W, Firlinger F, Poelz W, Lenz K, Haltmayer MMueller T. Prognostic value of soluble ST2 in an unselected cohort of patients admitted to an intensive care unit – the Linz Intensive Care Unit (LICU) study. Clin Chim Acta 2012;413:587–93. [PubMed]

10. Lampl C, Steiner TJ, Mueller T, Mirvelashvili E, Djibuti M, Kukava M, Dzagnidze A, Jensen R, Stovner LJ, Katsarava Z. Will (or can) people pay for headache care in a poor country? J Headache Pain 2012:67-74. [PubMed]

1. Kaar GDieplinger B, Gabriel C, Haltmayer MMueller T. Proguanylin and prouroguanylin-assay evaluation and clinical analyte characterisation. Clin Chim Acta 2011:412;2277–83. [PubMed]

2. Dieplinger BEgger M, Poelz W, Gabriel C, Haltmayer MMueller T. Soluble ST2 is not independently associated with androgen and estrogen status in healthy males and females. Clin Chem Lab Med 2011;49:1515-8. [PubMed]

3. Kralik JM, Kranewitter W, Boesmueller H, Marschon R, Tschurtschenthaler G, Rumpold H, Wiesinger K, Erdel M, Petzer AL, Webersinke G. Characterization of a newly identified ETV6-NTRK3 fusion transcript in acute myeloid leukemia. Diagn Pathol 2011:15;6:19. [PubMed]

4. Manzano-Fernandez S, Mueller T, Pascual-Figal D, Truong Q, Januzzi JL. Usefulness of soluble concentrations of the interleukin family member ST2 as predictor of mortality in patients with acutely decompensated heart failure relative to left ventricular ejection fraction. Am J Cardiol 2011;107:259-67. [PubMed]

1. Januzzi JL Jr, Rehman S, Mueller T, van Kimmenade RR, Lloyd-Jones DM. Importance of biomarkers for long-term mortality prediction in acutely dyspneic patients. Clin Chem 2010;56:1814-21. [PubMed]

2. Gretarsdottir S, Baas AF, Thorleifsson G, Holm H, den Heijer M, de Vries JP, Kranendonk SE, Zeebregts CJ, van Sterkenburg SM, Geelkerken RH, van Rij AM, Williams MJ, Boll AP, Kostic JP, Jonasdottir A, Jonasdottir A, Walters GB, Masson G, Sulem P, Saemundsdottir J, Mouy M, Magnusson KP, Tromp G, Elmore JR, Sakalihasan N, Limet R, Defraigne JO, Ferrell RE, Ronkainen A, Ruigrok YM, Wijmenga C, Grobbee DE, Shah SH, Granger CB, Quyyumi AA, Vaccarino V, Patel RS, Zafari AM, Levey AI, Austin H, Girelli D, Pignatti PF, Olivieri O, Martinelli N, Malerba G, Trabetti E, Becker LC, Becker DM, Reilly MP, Rader DJ, Mueller TDieplinger BHaltmayer M, Urbonavicius S, Lindblad B, Gottsäter A, Gaetani E, Pola R, Wells P, Rodger M, Forgie M, Langlois N, Corral J, Vicente V, Fontcuberta J, España F, Grarup N, Jørgensen T, Witte DR, Hansen T, Pedersen O, Aben KK, de Graaf J, Holewijn S, Folkersen L, Franco-Cereceda A, Eriksson P, Collier DA, Stefansson H, Steinthorsdottir V, Rafnar T, Valdimarsson EM, Magnadottir HB, Sveinbjornsdottir S, Olafsson I, Magnusson MK, Palmason R, Haraldsdottir V, Andersen K, Onundarson PT, Thorgeirsson G, Kiemeney LA, Powell JT, Carey DJ, Kuivaniemi H, Lindholt JS, Jones GT, Kong A, Blankensteijn JD, Matthiasson SE, Thorsteinsdottir U, Stefansson K. Genome-wide association study identifies a sequence variant within the DAB2IP gene conferring susceptibility to abdominal aortic aneurysm. Nat Genet 2010;42:692-7. [PubMed]

3. Dieplinger BEgger M, Poelz W, Haltmayer MMueller T. Long-term stability of soluble ST2 in frozen plasma samples. Clin Biochem 2010;43:1169-70. [PubMed]

4. Thorgeirsson TE, Gudbjartsson DF, Surakka I, Vink JM, Amin N, Geller F, Sulem P, Rafnar T, Esko T, Walter S, Gieger C, Rawal R, Mangino M, Prokopenko I, Mägi R, Keskitalo K, Gudjonsdottir IH, Gretarsdottir S, Stefansson H, Thompson JR, Aulchenko YS, Nelis M, Aben KK, den Heijer M, Dirksen A, Ashraf H, Soranzo N, Valdes AM, Steves C, Uitterlinden AG, Hofman A, Tönjes A, Kovacs P, Hottenga JJ, Willemsen G, Vogelzangs N, Döring A, Dahmen N, Nitz B, Pergadia ML, Saez B, De Diego V, Lezcano V, Garcia-Prats MD, Ripatti S, Perola M, Kettunen J, Hartikainen AL, Pouta A, Laitinen J, Isohanni M, Huei-Yi S, Allen M, Krestyaninova M, Hall AS, Jones GT, van Rij AM, Mueller TDieplinger BHaltmayer M, Jonsson S, Matthiasson SE, Oskarsson H, Tyrfingsson T, Kiemeney LA, Mayordomo JI, Lindholt JS, Pedersen JH, Franklin WA, Wolf H, Montgomery GW, Heath AC, Martin NG, Madden PA, Giegling I, Rujescu D, Järvelin MR, Salomaa V, Stumvoll M, Spector TD, Wichmann HE, Metspalu A, Samani NJ, Penninx BW, Oostra BA, Boomsma DI, Tiemeier H, van Duijn CM, Kaprio J, Gulcher JR; The ENGAGE Consortium, McCarthy MI, Peltonen L, Thorsteinsdottir U, Stefansson K. Sequence variants at CHRNB3-CHRNA6 and CYP2A6 affect smoking behavior. Nat Genet 2010;42:448-53. [PubMed]

5. Dieplinger B, Gegenhuber A, Kaar G, Poelz W, Haltmayer MMueller T. Prognostic value of established and novel biomarkers in patients with shortness of breath attending an emergency department. Clin Biochem 2010;43:714-19. [PubMed]

6. Mueller TDieplinger B, Forstner T, Poelz W, Haltmayer M. Pregnancy-associated plasma protein-A as a marker for long-term mortality in patients with peripheral atherosclerosis: inconclusive findings from the Linz Peripheral Arterial Disease (LIPAD) study. Clin Chem Lab Med 2010;48:537-42. [PubMed]

7. Cadamuro J, Dieplinger B, Felder T, Kedenko I, Mueller THaltmayer M, Patsch W, Oberkofler H. Genetic determinants of acenocoumarol and phenprocoumon maintenance dose requirements. Eur J Clin Pharmacol 2010;66:253-60. [PubMed]

1. Dieplinger B, Gegenhuber A, Haltmayer MMueller T. Re: Novel biomarkers for the diagnosis of acute destabilised heart failure in patients with shortness of breath. Heart 2009;95:1627.

2. Dieplinger B, Januzzi JL Jr, Steinmair M, Gabriel C, Poelz W, Haltmayer MMueller T. Analytical and clinical evaluation of a novel high-sensitivity assay for measurement of soluble ST2 in human plasma - the Presage ST2 assay. Clin Chim Acta 2009;409:33-40. [PubMed]

3. Dieplinger BHaltmayer M, Poelz W, Mueller T. Value of adiponectin as predictor of 5-year all-cause mortality in patients with symptomatic peripheral arterial disease: results from the Linz Peripheral Arterial Disease (LIPAD) study. Clin Chim Acta 2009;408:87-91. [PubMed]

4. Gnewuch C, Liebisch G, Langmann T, Dieplinger BMueller THaltmayer M, Dieplinger H, Zahn A, Stremmel W, Rogler G, Schmitz G. Serum bile acid profiling reflects enterohepatic detoxification state and intestinal barrier function in inflammatory bowel disease. World J Gastroenterol 2009;15:3134-41. [PubMed]

5. Dieplinger B, Gegenhuber A, Haltmayer MMueller T. Evaluation of novel biomarkers for the diagnosis of acute destabilized heart failure in shortness-of-breath patients. Heart 2009;95:1508-13. [PubMed]

6. Lampl C, Huber G, Adl J, Luthringshausen G, Franz G, Marecek S, Weber J, Baumhackl U, Mueller T. Two different doses of Amitriptyline ER in the prophylaxis of migraine: long-term results and predictive factors. Eur J Neurol 2009;16:943-8. [PubMed]

7. Dieplinger B, Gegenhuber A, Poelz W, Haltmayer MMueller T. Prognostic value of increased adiponectin plasma concentrations in patients with acute destabilized heart failure. Clin Biochem 2009;42:1190-3. [PubMed]

8. Dieplinger BMueller T,  Kollerits B, Struck J, Ritz E, Eckardstein A, Haltmayer M, Kronenberg F. Pro-A-type natriuretic peptide and pro-adrenomedullin predict progression of chronic kidney disease: the MMKD Study. Kidney Int 2009;75:408-14. [PubMed

9. Dieplinger B, Gegenhuber A, Struck J, Poelz W, Langsteger W, Haltmayer MMueller T. Chromogranin A and C-terminal endothelin-1 precursor fragment add independent prognostic information to amino-terminal proBNP in patients with acute destabilized heart failure. Clin Chim Acta 2009;400:91-6. [PubMed]

10. Mueller TDieplinger B, Poelz W, Endler G, Wagner OF, Haltmayer M. Amino terminal pro-B-type natriuretic peptide as predictor of mortality in patients with symptomatic peripheral arterial disease: 5-year follow-up data from the Linz Peripheral Arterial Disease (LIPAD) study. Clin Chem 2009;55:68-77. [PubMed]

11. Mueller TDieplinger B, Poelz W, Haltmayer M. Utility of PFA-100 and Multiplate for assessment of aspirin and clopidogrel effects on platelet function in patients with cardiovascular disease. Clin Appl Thromb Hemost 2009;15:652-9. [PubMed

1. Rehman SU, Mueller T, Januzzi JL Jr. Characteristics of the Novel Interleukin Family Biomarker ST2 in Patients With Acute Heart Failure.
J Am Coll Cardiol 2008;52:1458-65. [PubMed]

2. Egger M, Binder M, Wewalka F, Dieplinger B, Kastler M, Lenz K. An unusual cause of severe abdominal pain. Z Gastroenterol 2008;46:876-9. [PubMed]

3. Mueller T, Schimetta W, Dieplinger B, Loeffler P, Rehm M,  Kreimeier U, Poelz W, Haltmayer M. Influence of hydroxyethyl starch (6% HES 130/0.4) administration on haematology and clinical chemistry parameters. Clin Chem Lab Med 2008;46:558-62. [PubMed]

4. Ponschab M, Hochmair N, Ghazwinian N, Mueller T, Plöchl W. Levosimendan infusion improves haemodynamics in elderly heart failure patients undergoing urgent hip fracture repair. Eur J Anaesthesiol 2008;25:627-33. [PubMed]

5. Rehman SU, Martinez-Rumayor A, Mueller T, Januzzi JL Jr. Independent and incremental prognostic value of multimarker testing in acute dyspnea: Results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study. Clin Chim Acta 2008;392:41-5. [PubMed]

6. Eller P, Schgoer W, Mueller T, Tancevski I, Demetz E, Duwensee K, Ritsch A, Haltmayer M, Patsch JR. The K121Q polymorphism of ENPP1 and peripheral arterial disease. Heart Vessels 2008;23:104-7. [PubMed]

7. Thorgeirsson TE, Geller F, Sulem P, Rafnar T, Wiste A, Magnusson KP, Manolescu A, Thorleifsson G, Stefansson H, Ingason A, Stacey SN, Bergthorsson JT, Thorlacius S, Gudmundsson J, Jonsson T, Jakobsdottir M, Saemundsdottir J, Olafsdottir O, Gudmundsson LJ, Bjornsdottir G, Kristjansson K, Skuladottir H, Isaksson HJ, Gudbjartsson T, Jones GT, Mueller T, Gottsäter A, Flex A, Aben KK, de Vegt F, Mulders PF, Isla D, Vidal MJ, Asin L, Saez B, Murillo L, Blondal T, Kolbeinsson H, Stefansson JG, Hansdottir I, Runarsdottir V, Pola R, Lindblad B, van Rij AM, Dieplinger BHaltmayer M, Mayordomo JI, Kiemeney LA, Matthiasson SE, Oskarsson H, Tyrfingsson T, Gudbjartsson DF, Gulcher JR, Jonsson S, Thorsteinsdottir U, Kong A, Stefansson K. A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature 2008;452:638-42. [PubMed

8. Mueller TDieplinger B, Gegenhuber A, Poelz W, Pacher R, Haltmayer M. Increased plasma concentrations of soluble ST2 are predictive for one-year mortality in patients with acute destabilized heart failure. Clin Chem 2008;54:752-6. [PubMed]

9. Schgoer W, Eller P, Mueller T, Tancevski I, Wehinger A, Ulmer H, Sandhofer A, Ritsch A, Haltmayer M, Patsch JR. The MTP -493TT genotype is associated with peripheral arterial disease: Results from the Linz Peripheral Arterial Disease (LIPAD) Study. Clin Biochem 2008;41:712-6. [PubMed

10. Schgoer W, Mueller T, Jauhiainen M, Wehinger A, Gander R, Tancevski I, Eller P, Ritsch A, Salzmann K, Haltmayer M, Ehnholm C, Patsch JR, Foeger B. Low phospholipid transfer protein (PLTP) is a risk factor for peripheral atherosclerosis. Atherosclerosis 2008;196:219-26. [PubMed]

1. Jackson D, Craven RA, Hutson RC, Graze I, Lueth P, Tonge RP, Shaw JL, Nickson JA, Rayner SJ, Johnston C, Dieplinger B, Hubalek M, Wilkinson N, Perren TJ, Kehoe S, Hall GD, Daxenbichler G, Dieplinger H, Selby PJ, Banks RE. Proteomic Profiling Identifies Afamin as a Potential Biomarker for Ovarian Cancer. Clin Cancer Res 2007;13:7370-9. [PubMed]

2. Dieplinger B, Schiefermeier N, Juchum-Pasquazzo M, Gstir R, Huber LA. The transcriptional corepressor TPA-inducible sequence 7 regulates adult axon growth through cellular retinoic acid binding protein II expression. Eur J Neurosci 2007;26:3358-67. [PubMed]

3. Ritsch A, Sonderegger G, Sandhofer A, Stanzl U, Tancevski I, Eller P, Schgoer W, Wehinger A, Mueller THaltmayer M, Patsch JR. Scavenger receptor class B type I polymorphisms and peripheral arterial disease. Metabolism 2007;56:1135-41. [PubMed]

4. Dieplinger B, Lingenhel A, Baumgartner N, Poelz W, Dieplinger H, Haltmayer M, Kronenberg F, Mueller T. Increased serum lipoprotein(a) concentrations and low molecular weight phenotypes of apolipoprotein(a) are associated with symptomatic peripheral arterial disease. Clin Chem 2007;53:1298-305. [PubMed]

5. Mueller TDieplinger B, Poelz W, Calatzis A, Haltmayer M. Utility of whole blood impedance aggregometry for the assessment of clopidogrel action using the novel Multiplate® analyzer - comparison with two flow cytometric methods. Thromb Res 2007;121:249-58. [PubMed]

6. Gegenhuber A, Struck J, Dieplinger B, Poelz W, Pacher R, Morgenthaler NG, Bergmann A, Haltmayer MMueller T. Comparative evaluation of B-type natriuretic peptide, mid-regional pro-A-type natriuretic peptide, mid-regional pro-adrenomedullin, and copeptin to predict one-year mortality in patients with acute destabilized heart failure. J Card Fail 2007;13:42-9. [PubMed]

7. Frischmann ME, Kronenberg F, Trenkwalder E, Schaefer J, Schweer H, Dieplinger B, Koenig P, Ikewaki K, Dieplinger H. In vivo turnover study demonstrates diminished clearance of lipoprotein(a) in hemodialysis patients. Kidney Int 2007;71:1036-43. [PubMed]

8. Reisinger J, Hollinger K, Lang W, Steiner C, Winter T, Zeindlhofer E, Mori M, Schiller A, Lindorfer A, Wiesinger K, Siostrzonek P. Prediction of neurological outcome after cardiopulmonary resuscitation by serial determination of serum neuron-specific enolase. Eur Heart J 2007;28:52-8. [PubMed]

9. Dieplinger B, Poelz W, Haltmayer MMueller T. Association of adiponectin and amino terminal proBNP in peripheral arterial disease. Clin Chim Acta 2007;377:172-97. [PubMed]

1. Mueller THaltmayer M. Natriuretic peptide measurements as part of the diagnostic work-up in pleural effusions: an emerging concept? Eur Resp J 2006;28:7-9. [PubMed]

2. Dieplinger B, Poelz W, Haltmayer MMueller T. Hypoadiponectinemia is associated with symptomatic atherosclerotic peripheral arterial disease. Clin Chem Lab Med 2006;44:830-3. [PubMed]

3. Mueller TDieplinger B, Poelz W, Haltmayer M. Increased pregnancy-associated plasma protein-A as a marker for peripheral atherosclerosis: results from the Linz Peripheral Arterial Disease study. Clin Chem 2006;52:1096-103. [PubMed]

4. Gegenhuber A, Mueller TDieplinger B, Poelz W, Pacher R, Haltmayer M. B-type natriuretic peptide and amino terminal proBNP predict one-year mortality in short of breath patients independently of the baseline diagnosis of acute destabilized heart failure. Clin Chim Acta 2006;370:174-9. [PubMed]

5. Gegenhuber A, Struck J, Poelz W, Pacher R, Morgenthaler NG, Bergmann A, Haltmayer MMueller T. Utility of mid-regional pro-A-type natriuretic peptide measurements for the diagnosis of acute destabilized heart failure in short-of-breath patients presenting to an emergency department: comparison with B-type natriuretic peptide (BNP) and amino-terminal proBNP. Clin Chem 2006;52:827-31. [PubMed

1. Mueller T, Gegenhuber A, Dieplinger B, Poelz W, Haltmayer M. Capability of B-type natriuretic peptide (BNP) and amino-terminal proBNP as indicators of cardiac structural disease in asymptomatic patients with systemic arterial hypertension. Clin Chem 2005;51:2245-51. [PubMed]

2. Mueller T, Gegenhuber A, Haltmayer M. Levosimendan reduces plasma amino terminal proBNP in patients with decompensated heart failure. Int J Cardiol 2005;104:355-6. [PubMed]

3. Ikewaki K, Schaefer JR, Frischmann ME, Okubo K, Hosoya T, Mochizuki S, Dieplinger B, Trenkwalder E, Schweer H, Kronenberg F, Koenig P, Dieplinger H. Delayed in vivo catabolism of intermediate-density lipoprotein and low-density lipoprotein in hemodialysis patients as potential cause of premature atherosclerosis. Arterioscler Thromb Vasc Biol 2005;25:2615-22. [PubMed]

4. Eller P, Schgoer W, Mueller T, Tancevski I, Wehinger A, Ulmer H, Foeger B, Haltmayer M, Ritsch A, Patsch JR. Hepatic lipase polymorphism and increased risk of peripheral arterial disease. J Intern Med 2005;258:344-8. [PubMed]

5. Gegenhuber A, Mueller TDieplinger B, Lenz K, Poelz W, Haltmayer M. Plasma B-type natriuretic peptide in patients with pleural effusions: preliminary observations. Chest 2005;128:1003-9. [PubMed]

6. Jerkovic L, Voegele A, Kronenberg F, Radcliffe C, Wormald M, Lobentanz E, Eller P, Dejori N, Dieplinger B, Lüth P, Lottspeich F, Lichtenstein H, Sattler W, Mechtler K, Dwek R, Rudd P, Baier G, Dieplinger H. Afamin is a novel vitamin E-binding vlycoprotein. Characterisation and in vitro Expression. J Proteome Res 2005; 4:889-99. [PubMed]

7. Mueller T, Marschon R, Dieplinger B, Haidinger D, Gegenhuber A, Poelz W, Webersinke G, Haltmayer M. Factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations are not associated with chronic limb ischemia: The Linz Peripheral Arterial Disease (LIPAD) study. J Vasc Surg 2005;41:808-15. [PubMed]

8. Mueller T, Gegenhuber A, Poelz W, Haltmayer M. Diagnostic accuracy of B type natriuretic peptide and amino terminal proBNP in the emergency diagnosis of heart failure. Heart 2005;91:606-12. [PubMed]

9. Oberkofler H, Iglseder B, Klein K, Unger J, Haltmayer M, Krempler F, Paulweber B, Patsch W. Associations of the UCP2 gene locus with asymptomatic carotid atherosclerosis in middle-aged women. Arterioscler Thromb Vasc Biol 2005;25:604-10. [PubMed

1. Mueller TDieplinger B, Gegenhuber A, Haidinger D, Schmid N, Roth N, Ebner F, Landl M, Poelz W, Haltmayer M. Serum total 8-iso-prostaglandin F2alpha: A new and independent predictor of peripheral arterial disease. J Vasc Surg 2004;40:768-73. [PubMed]

2. Mueller T, Gegenhuber A, Dieplinger B, Poelz W, Haltmayer M. Long-term stability of endogenous B-type natriuretic peptide (BNP) and amino terminal proBNP (NT-proBNP) in frozen plasma samples. Clin Chem Lab Med 2004;42:942-4. [PubMed]

3. Haltmayer MMueller T, Poelz W. Hyperhomocysteinemia and severity of peripheral vascular disease: a rebuttal. J Thromb Haemost 2004;2:1212-3. [PubMed]

4. Vadivelu SK, Kurzbauer R, Dieplinger B, Zweyer M, Schafer R, Wernig A, Vietor I, Huber LA. Muscle regeneration and myogenic differentiation defects in mice lacking TIS7. Mol Cell Biol 2004 ;24:3514-25. [PubMed]

5. Mueller T, Gegenhuber A, Poelz W, Haltmayer M. Preliminary evaluation of the AxSYM B-type natriuretic peptide (BNP) assay and comparison with the ADVIA Centaur BNP assay. Clin Chem 2004;50:1104-6. [PubMed]

6. Haltmayer MMueller T, Gegenhuber A, Poelz W. Comparison of the automated AxSYM and ADVIA Centaur immunoassays for homocysteine determination. Clin Lab 2004;50:175-80. [PubMed]

7. Mueller T, Gegenhuber A, Poelz W, Haltmayer M. Biochemical diagnosis of impaired left ventricular ejection fraction comparison of the diagnostic accuracy of brain natriuretic peptide (BNP) and amino terminal proBNP (NT-proBNP). Clin Chem Lab Med 2004;42:159-63. [PubMed]

8. Mueller T, Gegenhuber A, Poelz W, Haltmayer M. Head-to-head comparison of the diagnostic utility of BNP and NT-proBNP in symptomatic and asymptomatic structural heart disease. Clin Chim Acta 2004;341:41-8. [PubMed]

9. Gegenhuber A, Mueller T, Firlinger F, Lenz K, Poelz W, Haltmayer M. Time course of B-type natriuretic peptide (BNP) and N-terminal proBNP changes in patients with decompensated heart failure. Clin Chem 2004;50:454-6. [PubMed]